COMBINATION THERAPY IN STAGE-C AND STAGE-D PROSTATIC-CANCER - RATIONALE AND 5-YEAR CLINICAL-EXPERIENCE

被引：2
|
作者：
LABRIE, F
DUPONT, A
BELANGER, A
CUSAN, L
GIGUERE, M
LACOURCIERE, Y
LUTHY, I
BEGIN, D
LABRIE, C
SIMARD, J
MONFETTE, G
EMOND, J
机构：
[1] UNIV LAVAL, MED CTR, DEPT MED, QUEBEC CITY G1V 4G2, QUEBEC, CANADA
[2] UNIV LAVAL, MED CTR, DEPT NUCL MED, QUEBEC CITY G1V 4G2, QUEBEC, CANADA
[3] HOTEL DIEU, DEPT UROL, ST JEROME, QUEBEC, CANADA
[4] HOTEL DIEU, DEPT UROL, LEVIS, QUEBEC, CANADA
来源：
CANCER AND METASTASIS REVIEWS | 1987年 / 6卷 / 04期
关键词：
D O I：
10.1007/BF00047470
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：615 / 636
页数：22
相关论文
共 50 条
  • [1] A PROSPECTIVE, RANDOMIZED CONTROLLED-STUDY ON THE TREATMENT OF STAGE-C AND STAGE-D PROSTATIC-CANCER WITH ESTRACYT IN COMBINATION WITH OTHER CHEMOTHERAPEUTIC-AGENTS
    AKAZA, H
    ISURUGI, K
    OISHI, Y
    KITAJIMA, K
    SAWAMURA, Y
    BABA, S
    YOSHIDA, K
    OTANI, M
    HARADA, M
    GUNJI, A
    ASO, Y
    NIIJIMA, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1988, 18 (04) : 343 - 355
  • [2] CISPLATIN, CYCLOPHOSPHAMIDE, AND PREDNISONE THERAPY FOR STAGE-D PROSTATIC-CANCER
    BERRY, J
    MACDONALD, RN
    CANCER TREATMENT REPORTS, 1982, 66 (06): : 1403 - 1404
  • [3] TREATMENT OF STAGE-D PROSTATIC-CANCER WITH AMINOGLUTHETHIMIDE
    BLOCK, M
    TRUMP, DL
    ROSE, DP
    HOGAN, TF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 149 - 149
  • [4] BUSERELIN AND FLUTAMIDE VERSUS SUBCAPSULAR ORCHIECTOMY AND FLUTAMIDE IN STAGE-C AND STAGE-D PROSTATIC-CANCER - A COST-BENEFIT RATIO ANALYSIS
    FRANZINI, A
    ALFANO, G
    ANTOLINI, C
    BORGHI, CM
    CICCHETTI, F
    VIGANO, P
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (08): : 1239 - 1239
  • [5] CHEMOTHERAPY OF HORMONE-RESISTANT STAGE-D PROSTATIC-CANCER
    SCHMIDT, JD
    JOURNAL OF UROLOGY, 1980, 123 (06): : 797 - 805
  • [6] MEGESTROL-ACETATE USED AS PRIMARY HORMONAL THERAPY IN STAGE-D PROSTATIC-CANCER
    BONOMI, P
    PESSIS, D
    BUNTING, N
    BLOCK, M
    ANDERSON, K
    WOLTER, J
    ROSSOF, A
    SLAYTON, R
    HARRIS, J
    SEMINARS IN ONCOLOGY, 1985, 12 (01) : 36 - 39
  • [7] LONG-TERM SURVIVAL AFTER HORMONAL THERAPY FOR STAGE-D PROSTATIC-CANCER
    REINER, WG
    SCOTT, WW
    EGGLESTON, JC
    WALSH, PC
    JOURNAL OF UROLOGY, 1979, 122 (02): : 183 - 184
  • [8] PROGNOSTIC INTEREST OF PROSTATIC ACID-PHOSPHATASE IN STAGE-B AND STAGE-C PROSTATIC-CANCER - A STUDY OF 84 CASES
    GUERIN, JL
    CANAL, P
    DOUCHEZ, J
    SOULA, G
    BULLETIN DU CANCER, 1989, 76 (10) : 1077 - 1082
  • [9] THE EFFECT OF HORMONE THERAPY ON PERIPHERAL-BLOOD LEUKOCYTIC SUBSET DISTRIBUTION IN STAGE-D PROSTATIC-CANCER PATIENTS
    RUBENSTEIN, M
    SHAW, MW
    MCKIEL, CF
    STOBNICKI, M
    ABLIN, RJ
    GUINAN, PD
    UROLOGICAL RESEARCH, 1985, 13 (02): : 67 - 71
  • [10] PROGNOSTIC VALUE OF PROSTATE-SPECIFIC ANTIGEN MINIMUM AFTER ORCHIECTOMY IN PATIENTS WITH STAGE-C AND STAGE-D PROSTATIC-CARCINOMA
    RIEDL, CR
    HUEBNER, WA
    MOSSIG, H
    OGRIS, E
    PFLUEGER, H
    BRITISH JOURNAL OF UROLOGY, 1995, 76 (01): : 34 - 40
12345